Fig. 3From: Development and verification of the PAM50-based Prosigna breast cancer gene signature assayDistribution of subtypes from subtype training samples. Log2 transformed, reference sample and geomean normalized, and gene scaled nCounter data from the BC no AST, WashU, UNC cohorts assessed by the trained NanoString Prosigna algorithmBack to article page